Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structural features enable selective interactions with neurotransmitter receptors, making it valuable in the development of novel antidepressants and antipsychotic agents. The compound's fluorinated aromatic and pyrrolidine moieties enhance blood-brain barrier permeability and metabolic stability, which are critical for CNS drug efficacy. It is also employed in structure-activity relationship (SAR) studies to optimize receptor binding affinity and selectivity during drug discovery.